New combo therapy shows promise in early cancer trial
Disease control
Completed
This early-stage study tested a new drug called COM902, alone or with another drug (COM701), in 94 people with advanced cancers like ovarian, lung, colon, and multiple myeloma. The main goal was to check safety and find the best dose. While not a cure, the approach aims to contro…
Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated May 14, 2026 12:04 UTC